EU Guidance On 'Significant Change' Meaning For Legacy Products Is Updated
Executive Summary
Now that the deadlines for legacy products under the EU’s Medical Device Regulation have been extended, the vital guidance on the meaning of “significant change” and conditions for ongoing sale of these products has also been updated.
You may also be interested in...
How Manufacturers Can Demonstrate Their 'Outdated' Legacy Certificates Remain Valid
It’s here! Notified bodies now have a means of showing which products are eligible to benefit from extended timelines as a result of the recent EU Medical Device Regulation amending regulation.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.